Labeling Human Melanoma Cells With SPIO

Objectives: To use the superparamagnetic iron oxide (SPIO) contrast agent Resovist (±transfection agent) to label human melanoma cells and determine its effects on cellular viability, microstructure, iron quantity, and magnetic resonance imaging (MRI) detectability. Materials and Methods: Human SK-M...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel Spira MD, Rüdiger Bantleon PhD, Hartwig Wolburg PhD, Fritz Schick MD, PhD, Gerd Groezinger MD, Jakub Wiskirchen MD, Benjamin Wiesinger MD
Format: Article
Language:English
Published: SAGE Publishing 2016-01-01
Series:Molecular Imaging
Online Access:https://doi.org/10.1177/1536012115624915
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841563178637459456
author Daniel Spira MD
Rüdiger Bantleon PhD
Hartwig Wolburg PhD
Fritz Schick MD, PhD
Gerd Groezinger MD
Jakub Wiskirchen MD
Benjamin Wiesinger MD
author_facet Daniel Spira MD
Rüdiger Bantleon PhD
Hartwig Wolburg PhD
Fritz Schick MD, PhD
Gerd Groezinger MD
Jakub Wiskirchen MD
Benjamin Wiesinger MD
author_sort Daniel Spira MD
collection DOAJ
description Objectives: To use the superparamagnetic iron oxide (SPIO) contrast agent Resovist (±transfection agent) to label human melanoma cells and determine its effects on cellular viability, microstructure, iron quantity, and magnetic resonance imaging (MRI) detectability. Materials and Methods: Human SK-Mel28 melanoma cells were incubated with Resovist (±liposomal transfection agent DOSPER). The cellular iron content was measured, and labeled cells were examined at 1.5 T and 3.0 T. The intracellular and extracellular distributions of the contrast agent were assessed by light and electron microscopy. Results: The incubation of melanoma cells with SPIO does not interfere with cell viability or proliferation. The iron is located both intracellularly and extracellularly as iron clusters associated with the exterior of the cell membrane. Despite thorough washing, the extracellular SPIO remained associated with the cell membrane. The liposomal transfection agent does not change the maximum achievable cellular iron content but promotes a faster iron uptake. The MRI detectability persists for at least 7 days. Conclusion: The transfection agent DOSPER facilitates the efficient labeling of human metastatic melanoma cells with Resovist. Our findings raise the possibility that other Resovist-labeled cells may collect associated extracellular nanoparticles. The SPIO may be available to other iron-handling cells and not completely compartmentalized during the labeling procedure.
format Article
id doaj-art-df7f0178db39470ea0414093dccbc0b0
institution Kabale University
issn 1536-0121
language English
publishDate 2016-01-01
publisher SAGE Publishing
record_format Article
series Molecular Imaging
spelling doaj-art-df7f0178db39470ea0414093dccbc0b02025-01-03T00:10:41ZengSAGE PublishingMolecular Imaging1536-01212016-01-011510.1177/153601211562491510.1177_1536012115624915Labeling Human Melanoma Cells With SPIODaniel Spira MD0Rüdiger Bantleon PhD1Hartwig Wolburg PhD2Fritz Schick MD, PhD3Gerd Groezinger MD4Jakub Wiskirchen MD5Benjamin Wiesinger MD6Department of Diagnostic and Interventional Radiology, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 110, 69120 HeidelbergDepartment of Diagnostic and Interventional Radiology, Eberhard-Karls-University Tübingen, Hoppe-Seyler-Str. 3, 72076 Tübingen, GermanyInstitute of Pathology and Neuropathology, Eberhard-Karls-University Tübingen, Liebermeisterstraße 8, 72076 Tübingen, GermanySection on Experimental Radiology, Eberhard-Karls-University Tübingen, Hoppe-Seyler-Str. 3, 72076 Tübingen, GermanyDepartment of Diagnostic and Interventional Radiology, Eberhard-Karls-University Tübingen, Hoppe-Seyler-Str. 3, 72076 Tübingen, GermanyDepartment of Radiology and Nuclear Medicine, Franziskus Hospital Bielefeld, Kiskerstraße 26, 33615 Bielefeld, GermanyDepartment of Diagnostic and Interventional Radiology, Eberhard-Karls-University Tübingen, Hoppe-Seyler-Str. 3, 72076 Tübingen, GermanyObjectives: To use the superparamagnetic iron oxide (SPIO) contrast agent Resovist (±transfection agent) to label human melanoma cells and determine its effects on cellular viability, microstructure, iron quantity, and magnetic resonance imaging (MRI) detectability. Materials and Methods: Human SK-Mel28 melanoma cells were incubated with Resovist (±liposomal transfection agent DOSPER). The cellular iron content was measured, and labeled cells were examined at 1.5 T and 3.0 T. The intracellular and extracellular distributions of the contrast agent were assessed by light and electron microscopy. Results: The incubation of melanoma cells with SPIO does not interfere with cell viability or proliferation. The iron is located both intracellularly and extracellularly as iron clusters associated with the exterior of the cell membrane. Despite thorough washing, the extracellular SPIO remained associated with the cell membrane. The liposomal transfection agent does not change the maximum achievable cellular iron content but promotes a faster iron uptake. The MRI detectability persists for at least 7 days. Conclusion: The transfection agent DOSPER facilitates the efficient labeling of human metastatic melanoma cells with Resovist. Our findings raise the possibility that other Resovist-labeled cells may collect associated extracellular nanoparticles. The SPIO may be available to other iron-handling cells and not completely compartmentalized during the labeling procedure.https://doi.org/10.1177/1536012115624915
spellingShingle Daniel Spira MD
Rüdiger Bantleon PhD
Hartwig Wolburg PhD
Fritz Schick MD, PhD
Gerd Groezinger MD
Jakub Wiskirchen MD
Benjamin Wiesinger MD
Labeling Human Melanoma Cells With SPIO
Molecular Imaging
title Labeling Human Melanoma Cells With SPIO
title_full Labeling Human Melanoma Cells With SPIO
title_fullStr Labeling Human Melanoma Cells With SPIO
title_full_unstemmed Labeling Human Melanoma Cells With SPIO
title_short Labeling Human Melanoma Cells With SPIO
title_sort labeling human melanoma cells with spio
url https://doi.org/10.1177/1536012115624915
work_keys_str_mv AT danielspiramd labelinghumanmelanomacellswithspio
AT rudigerbantleonphd labelinghumanmelanomacellswithspio
AT hartwigwolburgphd labelinghumanmelanomacellswithspio
AT fritzschickmdphd labelinghumanmelanomacellswithspio
AT gerdgroezingermd labelinghumanmelanomacellswithspio
AT jakubwiskirchenmd labelinghumanmelanomacellswithspio
AT benjaminwiesingermd labelinghumanmelanomacellswithspio